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Abstract
The potential of the diverse chemistries present in natural products (NP) for biotechnology and 
medicine remains untapped because NP databases are not searchable with raw data and the NP 
community has no way to share data other than in published papers. Although mass spectrometry 
techniques are well-suited to high-throughput characterization of natural products, there is a 
pressing need for an infrastructure to enable sharing and curation of data. We present Global 
Natural Products Social molecular networking (GNPS, http://gnps.ucsd.edu), an open-access 
knowledge base for community wide organization and sharing of raw, processed or identified 
tandem mass (MS/MS) spectrometry data. In GNPS crowdsourced curation of freely available 
community-wide reference MS libraries will underpin improved annotations. Data-driven social-
networking should facilitate identification of spectra and foster collaborations. We also introduce 
the concept of ‘living data’ through continuous reanalysis of deposited data.
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Introduction
Natural products (NPs) from marine and terrestrial environments, including their inhabiting 
microorganisms, plants, animals, and humans, are routinely analyzed using mass 
spectrometry. However a single mass spectrometry experiment can collect thousands of 
MS/MS spectra in minutes1 and individual projects can acquire millions of spectra. These 
datasets are too large for manual analysis. Further, comprehensive software and proper 
computational infrastructure are not readily available and only low-throughput sharing of 
either raw or annotated spectra is feasible, even among members of the same lab. The 
potentially useful information in MS/MS datasets can thus remain buried in papers, 
laboratory notebooks, and private databases, hindering retrieval, mining, and sharing of data 
and knowledge. Although there are several NP databases — Dictionary of Natural 
Products2, AntiBase3 and MarinLit4 — that assist in dereplication (identification of known 
compounds), these resources are not freely available and do not process mass spectrometry 
data. Conversely, mass spectrometry databases including Massbank5, Metlin6, mzCloud7, 
and ReSpect8 host MS/MS spectra but limit data analyses to several individual spectra or a 
few LC-MS files. While Metlin and mzCloud provide a spectrum search function, 
unfortunately, their libraries are not freely available.
Global genomics and proteomics research has been facilitated by the development of 
integral resources such as the National Center for Biotechnology Information (NCBI) and 
UniProt KnowledgeBase (UniProtKB), which provide robust platforms for data sharing and 
knowledge dissemination9,10. Recognizing the need for an analogous community platform to 
effectively share and analyze natural products MS data, we present the Global Natural 
Products Social Molecular Networking (GNPS, available at gnps.ucsd.edu). GNPS is a data-
driven platform for the storage, analysis, and knowledge dissemination of MS/MS spectra 
that enables community sharing of raw spectra, continuous annotation of deposited data, and 
collaborative curation of reference spectra (referred to as spectral libraries) and experimental 
data (organized as datasets).
GNPS provides the ability to analyze a dataset and to compare it to all publically available 
data. By building on the computational infrastructure of the University of California San 
Diego (UCSD) Center for Computational Mass Spectrometry (CCMS), GNPS provides 
public dataset deposition/retrieval through the Mass Spectrometry Interactive Virtual 
Environment (MassIVE) data repository. The GNPS analysis infrastructure further enables 
online dereplication6,11–13, automated molecular networking analysis14–21, and 
crowdsourced MS/MS spectrum curation. Each dataset added to the GNPS repository is 
automatically reanalyzed in the next monthly cycle of continuous identification (see Living 
Data by Continuous Analysis below). Each of these tens of millions of spectra in GNPS 
datasets is matched to reference spectral libraries to annotate molecules and to discover 
putative analogs (Fig. 1a). From January 2014 to November 2015, GNPS has grown to serve 
9,267 users from 100 countries (Fig. 1b), with 42,486 analysis sessions that have processed 
more than 93 million spectra as molecular networks from a quarter million LC-MS runs. 
Searches against a combined catalog of over 221,000 MS/MS reference library spectra from 
18,163 compounds (Supplementary Table 1) are possible, and GNPS has matched almost 
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one hundred million MS/MS spectra in all public and private search jobs using an estimated 
84,000 compute hours.
GNPS Spectral Libraries
GNPS spectral libraries enable dereplication, variable dereplication (approximate matches to 
spectra of related molecules), and identification of spectra in molecular networks. GNPS has 
collected available MS/MS spectral libraries relevant to NPs (which also include other 
metabolites and molecules), including MassBank5, ReSpect8 and NIST22 (Table 1, Fig. 2a, 
and Supplementary Table 1). Altogether, these third party libraries total 212,230 MS/MS 
spectra representing 12,694 unique compounds (Fig. 2b). While this combined collection of 
reference spectra, provides a starting point for dereplication, only 1.01% of all spectra public 
GNPS datasets has been matched to this collection, indicating insufficient chemical space 
coverage. Although the NP community is working to populate this “missing” chemical 
space, there is no way to report discoveries of chemistries in an easily verifiable and reusable 
format.
To begin to address this pressing need, GNPS houses both newly-acquired reference spectra 
(GNPS-Collections) as well as a crowd-sourced library of community-contributed reference 
spectra (GNPS-Community). GNPS-Collections includes NPs and pharmacologically active 
compounds totaling 6,629 MS/MS spectra of 4,243 compounds (Fig 2b, Supplementary 
Table 1, Supplementary Note 1,2, and Supplementary Table 2). The GNPS-Community 
library has grown to include 2,224 MS/MS spectra of 1,325 compounds from 55 worldwide 
contributors. While the total number of MS/MS spectra in GNPS libraries is only 4% of the 
MS/MS spectra collected in third party libraries, GNPS libraries contribute matches of 
MS/MS spectra at a scale disproportionate to their size (Fig. 2c). The GNPS libraries 
account for 29% of unique compound matches and 59% of the MS/MS matches in public 
(88% of public+private) data. This indicates that the GNPS libraries contain compounds that 
are complementary to the chemical space represented in other libraries (Fig. 2c,d). 
Moreover, in contrast to third party libraries, spectra submitted to GNPS-Community 
libraries are immediately searchable by the whole community, such that submissions 
seamlessly transfer knowledge between laboratories (Fig. 1a) in a process that is akin to the 
addition of genome annotations to GenBank9.
In order to create a robust library, it is important for submissions to be peer-reviewed and, if 
necessary, annotations corrected or updated as appropriate. Reference spectra submitted to 
the GNPS-Community library are categorized by the estimated reliability of the proposed 
submissions. Gold reference spectra must be derived from structurally characterized 
synthetic or purified compounds and can only be submitted by approved users. Approval is 
given to contributors who have undergone training. Training is initiated by contacting the 
corresponding authors or CCMS administrators. Silver reference spectra need to be 
supported by an associated publication, while Bronze reference spectra are all remaining 
putative annotations (Supplementary Table 3). This type of division of spectra is reminiscent 
of RefSeq/TPA/GenBank9,23 (genomics) and Swiss-Prot/TrEMBL/UniProt24,25 
(proteomics), allowing for varying tradeoffs between comprehensiveness and reliability of 
annotations defined as Gold, Silver, and Bronze (Fig. 2e).
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To enable refinements or corrections of annotations, GNPS allows for community-driven, 
iterative re-annotation of reference MS/MS spectra in a wiki-like fashion, to progressively 
improve the library and converge towards consensus annotation of all MS/MS spectra of 
interest. This is a process similar to the iterative annotation of the human genome (e.g., see 
series of papers on NCBI GenBank9). To date, 563 annotation revisions have been made in 
GNPS (Supplementary Table 4), most of which added metadata to library spectra or refined 
compound names. The history of each annotation is retained so that users can discuss the 
proper annotation and address disagreements via comment threads.
Dereplication using GNPS
High throughput dereplication of NP MS/MS data is implemented in GNPS by querying 
newly acquired MS/MS spectra against all the accumulated reference spectra in GNPS 
spectral libraries (Fig. 3a). To date, more than 93 million MS/MS spectra from various 
instruments (including Orbitrap, Ion Trap, qTof, and FT-ICR) have been searched at GNPS, 
yielding putative dereplication matches of 7.7 million spectra to 15,477 compounds. In the 
second stage of dereplication, GNPS goes beyond re-identification by utilizing variable 
dereplication, which is a modification-tolerant spectral library search that is mediated by a 
spectral alignment algorithm. Variable dereplication enables the detection of significant 
matches to either putative analogs of known compounds (e.g., differing by one modification 
or substitution of a chemical group) or compounds belonging to the same general class of 
molecules (Fig. 3b).Variable dereplication is not available through any other computational 
platform. For example, GNPS variable dereplication has detected compounds with different 
levels of glycosylation on various substrates. As MS/MS fragmentation preferentially results 
in peaks from glycan fragments, it is possible to detect sets of compounds with related 
glycans even when the substrates to which the glycans are attached are themselves 
unrelated26. To date, 3,891 putative analogs have been identified in public data using GNPS 
variable dereplication (Supplementary Table 5). These 3,891 putative analogs include several 
unique molecules that could be user-curated and added to GNPS reference libraries (see 
Molecular Explorer below on accessing and annotating putative analogs).
To assess the reliability of the MS/MS matches found by GNPS dereplication, GNPS users 
can rate the quality of matches returned by automated GNPS reanalysis (see below). These 
ratings are 4 star (correct), 3 star (likely correct, e.g. could also be isomers with similar 
fragmentation patterns), 2 star (unable to confirm the annotation due to limited information) 
and 1 star (incorrect) (Supplementary Table 6). So far, of the 3,608 matches that have been 
rated, 139 (3.9%) matches were given 1 or 2 stars (insufficient information (2.9%) or 
incorrect (1%)) by user ratings. These percentages are consistent with the false discovery 
rates estimated using spectral library searches of benchmark LC-MS datasets with 
compound standards (Supplementary Note 3, Supplementary Fig. 1,2 and Supplementary 
Table 7). Furthermore, these 3,608 match ratings were associated with 2,041 library spectra, 
therefore the average rating of a library spectrum can offer insight into the reliability of its 
reference annotation, not unlike Yelp ratings for restaurants. Incorrect matches can arise 
through either spurious high-scoring matches to library spectra or incorrect annotations for 
library spectra. Of the 2,041 library spectra with match ratings, 72 (3.5%) spectra had 
average ratings below 2.5 stars. These percentage ratings were further broken down by 
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spectral library (Fig. 2e). We found that for GNPS-Collection and GNPS-Community 
libraries, only 29 out of 1746 (1.7%) of the rated library spectra had average ratings below 
2.5 stars. These ratings demonstrate that the perceived reliability of GNPS spectral libraries 
compares favorably with established community resources such as NIST and Massbank, in 
which 10.5% and 20.1% of the ratings were below 2.5 stars respectively, and provides 
confidence that the community curation process is robust and that third party libraries 
integrate well with GNPS. The main advantages of searching using GNPS are the option to 
run simple or variable dereplication against all publicly accessible reference spectra, and that 
community-rated matches can be used to improve the quality of the reference libraries and 
matching algorithms. These dereplication capabilities are not possible with existing 
published resources.
Molecular Networking
Molecular networks are visual displays of the chemical space present in mass spectrometry 
experiments. GNPS can be used for molecular networking14–21,27,28, a spectral correlation 
and visualization approach that can detect sets of spectra from related molecules (so-called 
spectral networks29) even when the spectra themselves are not matched to any known 
compounds (Fig. 3a). Spectral alignment15,27 detects similar spectra from structurally 
related molecules, assuming these molecules fragment in similar ways reflected in their 
MS/MS patterns (Fig. 3b), analogous to the detection of related protein or nucleotide 
sequences by sequence alignment. GNPS is currently the only public infrastructure that 
enables molecular networking. The visualization of molecular networks in GNPS represents 
each spectrum as a node, and spectrum-to-spectrum alignments as edges (connections) 
between nodes. Nodes can be supplemented with metadata, including dereplication matches 
or information that is provided by the user, such as abundance, origin of product, 
biochemical activity or hydrophobicity which can be reflected in a node’s size or color. It is 
possible to visualize the map of related molecules as a molecular network21,30–33 
(Supplementary Fig. 3) both online at GNPS (Fig. 3c) or exported for analysis in 
Cytoscape31. Molecular networking analyses of 272 public datasets (Fig. 4a) from a diverse 
range of samples reveals that on average 35.2% of all unidentified nodes are significantly 
matched to other spectra of related molecules within a cosine score of 0.8 (increasing to 
44.7% of all nodes in more exploratory networks with a cosine score of 0.65 – See 
Supplementary Table 8). This indicates that a large fraction of all unidentified spectra are 
identifiable if their or their neighboring nodes’ reference spectra were available in the 
reference spectral libraries.
Living Data by Continuous Analysis
Funding agencies and publishers have called for raw scientific data, including mass 
spectrometry data, and analysis methods to be made publically available where possible. 
Consistent with this aim, GNPS datasets usually comprise the full set of mass spectrometry 
files produced during a NP research project or the full set of spectra analyzed for a peer-
reviewed publication (Supplementary Note 4). While it is potentially advantageous to the 
community for all data to be made public, GNPS user data can remain private until users 
explicitly choose to make it public (private data is also analyzable and privately sharable, 
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with >93 million spectra in >250,000 private LC/MS runs already searched using GNPS). 
GNPS has the largest collection of publicly accessible natural product and metabolomics 
MS/MS datasets and is the only infrastructure where public data sets can be reanalyzed 
together and compared with each other (Table 1). To date, GNPS has made 272 public 
GNPS datasets openly available which are comprised of more than 30,000 mass 
spectrometry runs with approximately 84 million MS/MS spectra. In common with other 
public repositories34,35, GNPS datasets can be downloaded. However, data availability on its 
own does not serve to enable data reuse. GNPS is unique among MS repositories by 
enabling continuous identification: the periodic and automated re-analysis of all public 
datasets (Supplementary Note 5,6 and Supplementary Table 9,10). This continuous re-
analysis, which incorporates molecular networking and dereplication tools, implements a 
‘virtuous cycle’ as illustrated in Figure 1a. Because GNPS spectral libraries are constantly 
growing due to community contributions and continued generation of reference spectra, the 
number of matches made by successive re-analyses of public datasets has already grown and 
is expected to continue to grow over time (Fig. 4b). GNPS users are periodically updated 
with alerts of new search results.
For example, a Streptomyces roseosporeus project (MSV000078577) was deposited April 8, 
2014. At first, only 7 MS/MS spectra were matched. However as of July 14, 2015 36 
spectral matches have been made to GNPS libraries. Overall, the total number of compounds 
matched to GNPS datasets increased more than tenfold, while the number of matched 
MS/MS spectra in GNPS datasets increased more than twenty-fold in 2015 (Fig. 4b). GNPS 
users can also subscribe to specific datasets of interest, rather like ‘following’ people on 
Twitter. When new matches are made, changed, or revoked, all subscribers are notified of 
new information by an email summarizing changes in identification. From April 2014 to 
July 2015, 45 updates were initiated by CCMS and automatically sent to subscribers 
(Supplementary Fig. 4). Update emails have led to substantially more views per dataset, 
compared to non-GNPS datasets (192 proteomics datasets) deposited in MassIVE. 
Continuous identification not only keeps a single dataset ‘alive’, it can create connections 
between datasets and users over time. Similarities between datasets could form the basis of a 
data-mediated social network of users with potentially related research interests despite 
seemingly disparate research fields, rather like the “People You May Know” feature on 
LinkedIn. On average each GNPS user already has 5 suggested collaborators 
(Supplementary Fig. 5).
Molecular Explorer
Molecular Explorer is a feature that can only be implemented on ‘living data’ repositories 
and thus exists only in GNPS. Molecular Explorer allows users to find all datasets and 
putative analogs that have ever been observed for a given molecule of interest. We anticipate 
that this feature could guide the discovery of previously unknown analogs of existing 
antibiotics. Public NP data contains more than one hundred unidentified putative analogs of 
antibiotics such as valinomycin, actinomycin, etamycin, hormaomycin, stendomycin, 
daptomycin, erythromycin, napsamycin, clindamycin, arylomycin, and rifamycin, 
highlighting a clear potential to generate leads to discover structurally related antibiotics 
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though the application of GNPS (Supplementary Fig. 6, Supplementary Table 5, and 
Supplementary Note 7).
To demonstrate this principle we searched for an analog of stenothricin, a broad spectrum 
antibiotic produced by S. roseosporus with a unique biological response profile36,37 
(Supplementary Fig. 7). MS/MS data from S. roseosporus and Streptomyces sp. DSM5940 
extracts (MSV000079204) were analyzed by molecular networking and dereplication in 
GNPS (Supplementary Note 8, Supplementary Fig. 8, and Supplementary Table 11). Nodes 
corresponding to the stenothricin37 from S. roseosporus were identified in the molecular 
network. In addition, a small sub-network corresponding to spectra from Streptomyces sp. 
DSM5940 (Fig. 5a) included 14 nodes that were 41 Da smaller than nodes already known to 
be stenothricin analogs. This sub-network seemed to indicate that Streptomyces sp. 
DSM5940 produces a set of 5 abundant analogs of stenothricin which we named 
stenothricin-GNPS 1-5 (Supplementary Table 12). To our knowledge, a chemical entity that 
is related to stenothricin with a mass shift of −41 Da has not been described in any database 
or in the literature. The most abundant analog, stenothricin-GNPS 2 (m/z 1105) was purified 
and the MS/MS spectra manually compared to MS/MS spectra produced from stenothricin 
D. This confirmed structural similarity (Fig. 5b,c Supplementary Fig. 9). Differential 2D 
NMR (Supplementary Fig. 10-14, Supplementary Table 13, and Supplementary Note 9), 
Marfey’s analysis38 (Supplementary Fig. 15), and genome mining (Supplementary Fig. 
16,17, Supplementary Table 14, and Supplementary Note 10) all support that the −41 Da 
mass shift is due to a lysine to serine substitution.
The structural comparison between stenothricin D and stenothricin-GNPS has identified a 
potential role for the lysine residue of stenothricin D in biological function. Stenothricin-
GNPS was subjected to fluorescence microscopy based bacterial cytological profiling39,40 
(Fig. 5d). Unlike stenothricin D, stenothricin-GNPS is only active against Escherichia coli 
lptD cells, which are defective in the essential outer membrane protein LptD 
(Supplementary Fig. 18 and Supplementary Note 11). Although both stenothricin D and 
stenothricin-GNPS increased membrane permeability of bacterial cells within two hours, 
stenothricin-GNPS did not have the membrane solubilization function of stenothricin D (Fig. 
5d), indicating that the activity of stenothricin D is altered by the presence of a lysine 
residue that is absent from stenothricin-GNPS. Several published applications of molecular 
networking and MS/MS based dereplication using GNPS have been reported while the 
infrastructure has been under development. Specifically, GNPS has enabled the discovery of 
natural products including colibactin41–45, characterization of biosynthetic pathways46,47, 
understanding of the chemistry of ecological interactions28,48–52, and development of 
metabolomics bioinformatics methods53. The application of GNPS workflows to such 
diverse research areas demonstrates its utility.
Conclusion
GNPS provides a community-led knowledge space in which NP data can be shared, 
analyzed and annotated by researchers worldwide. It enables a cycle of annotation, in which 
users curate data, continuous dereplication for product identification, and houses a 
knowledge base of reference spectral libraries and public datasets. Selected views from 
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community members were sought by nature Biotechnology and are presented, together with 
author responses, in BOX 1.
The transformation of deposited spectra into living data that is enabled by the GNPS 
platform could mediate connections between researchers and has the potential to transform 
data networks into social networks. Of 1,272 compound identifications obtained by 
continuous identification with the GNPS-Community library, 1,063 (83.6%) were made 
using reference spectra that were not uploaded by the submitter. In other words, the vast 
majority of identifications were enabled by other community members. This reuse of 
knowledge and data is analogous to other community-wide curation efforts including 
Wikipedia and crowd-sourced dictionaries. Since their initial deposition, 59% of datasets 
have an increased number of identifications, with the average dataset more than doubling the 
number of identifications since submission (Supplementary Fig. 19). GNPS enables facile 
sharing of individual analyses (Supplementary Fig. 20) and uses molecular networks to 
reveal connections between datasets from different laboratories and biological sources that 
would otherwise remain disconnected. To date, 3,145 analysis jobs have included files 
shared between GNPS users, encompassing 548 unique pairs of individuals’ collaborations. 
GNPS recasts public datasets as “conversation starters” in a data-mediated social network.
Although we have described only one simple application of GNPS in this Perspective 
( identification of a stenothricin analog), the community has already begun to utilize GNPS 
to expedite natural product analysis28,41,43,45,46,50,52. Furthermore, we expect the user base 
of GNPS to expand to include other communities that use MS/MS data, including those 
studying metabolomics, exposomes, the chemistry of the human habitat, drug discovery, 
microbiomes, immunology, food industry, agricultural industry, stratification of patients in 
clinical trials, clinical adsorption/metabolism and ocean science to name a few, resulting in 
different GNPS workflows42,44,47,51,53.
As previously shown in genomics9 and protein structure analysis54, the models of global 
collaboration and social cooperation that are present in GNPS could empower scientific 
communities to collectively translate big data into shared, reusable knowledge and 
profoundly influence the way we explore molecules using mass spectrometry.
Online Methods
Spectral Library Searching
Input MS/MS spectra (i.e., query spectra) are considered matched to library spectra if they 
meet the following criteria: same precursor charge state, precursor m/z is within a user 
defined Thompson tolerance, share a minimum number of matched peaks, and exceed a 
user-defined minimum spectral match score. Exact spectral matches between library and 
query spectra are scored with a normalized dot product57–59. The matching of peaks 
between two spectra is formulated as a maximum bipartite matching problem15 where peaks 
from the library and query spectra are represented as nodes with edges connecting library 
and query peaks. Edges connect peaks that are within a user defined fragment mass 
tolerance. The bipartite match of library to query peaks that maximizes the normalized dot 
product is selected. The highest scoring library match for each query spectrum is reported. 
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Estimated false discovery rates of the exact spectral library search are shown in 
Supplementary Note 3. Parameters of the search can be found in Supplementary Table 8. 
Source code can be found at the CCMS github page.
Variable Dereplication
Variable dereplication utilizes a modification tolerant spectral library search. Similar to exact 
spectral matches, except additional edges are added to the bipartite matching between library 
and query peaks which differ by a δ (as determined by their precursor mass difference δ) +/
− the user defined fragment mass tolerance.
Molecular Network Construction
Molecular networks can be constructed from any collection of MS/MS spectra. First, all 
MS/MS spectra are clustered with MSCluster60 such that MS/MS spectra found to be 
identical are merged into a consensus spectrum. Consensus spectra are then matched against 
each other using the modification tolerant spectral matching scheme15. All spectrum-to-
spectrum matches that exceed a user defined minimum match score are retained. MS/MS 
spectra are then represented as nodes in a graph and significant matches between spectra are 
represented as edges. Further, edges in the graph are only retained if the two nodes, A and B, 
connected by a given edge satisfy the following properties: i) B must be in the top K highest 
scoring neighbors of A and ii) A must be in the top K highest scoring neighbors of B. All 
other edges are removed. Source code can be found at the CCMS github page.
GNPS Collections – Sample Preparation
The NIH Prestwick Phytochemical Library, NIH Natural Product Library, and NIH Small 
Molecule Pharmacologically Active Library compounds were received as stock solutions of 
pure compounds (10 mM in DMSO). They were reformatted by 1 μL of each compound into 
89 μL of methanol into 96 well plates with 11 distinct compounds in each well. They were 
further diluted 100-fold for a final 1 μM concentration.
The NIH Clinical Collections and FDA Library part 2 were received as stock solutions of 
pure compounds (10 mM in DMSO). They were diluted to final concentration of 1 μM in 
50:50 methanol:water and formatted onto 96 well plates with 10 compounds per well.
GNPS Collections – LC MS/MS Acquisition
LC-MS/MS acquisition for all in house generated libraries was performed using a Bruker 
Daltonics Maxis qTOF mass spectrometer equipped with a standard electrospray ionization 
source (ESI). The mass spectrometer was tuned by infusion of Tuning Mix ES-TOF (Agilent 
Technologies) at a 3 μL/min flow rate. For accurate mass measurements, lock mass internal 
calibration used a wick saturated with hexakis (1H,1H,3H-tetrafluoropropoxy) phosphazene 
ions (Synquest Laboratories, m/z 922.0098) located within the source. Samples were 
introduced by a Thermo Scientific UltraMate 3000 Dionex UPLC using a 20 μL injection 
volume. A Phenomenex Kinetex 2.6 μm C18 column (2.1 mm × 50 mm) was used. 
Compounds from NIH Prestwick Phytochemical Library, NIH Natural Product Library, and 
NIH Small Molecule Pharmacologically Active Library were separated using a seven minute 
linear water-acetonitrile gradient (from 98:2 to 2:98 water:acetonitrile) containing 0.1% 
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formic acid. Compounds from NIH Clinical Collections and FDA Library part 2 Library 
employed a step gradient for chromatographic separation [5% solvent B (2:98 
water:acetonitrile) containing 0.1% formic acid for 1.5 min, a step gradient of 5% B-50% B 
in 0.5 min, held at 50% B for 2 min, a second step of 50% B-100% B in 6 min, held at 100% 
B for 0.5 min, 100%-5 % B in 0.5 min and kept at 5% B for 0.5 min]. The flow rate was 0.5 
mL/min. The mass spectrometer was operated in data dependent positive ion mode; 
automatically switching between full scan MS and MS/MS acquisitions. Full scan MS 
spectra (m/z 50 – 1500) were acquired in the TOF and the top ten most intense ions in a 
particular scan were fragmented using collision induced dissociation (CID) utilizing 
stepping.
GNPS Collections – Spectral Library Creation
All raw data were centroided and converted to 32-bit uncompressed mzXML file using 
Bruker Data Analysis. A script was developed to select all possible MS/MS spectra in each 
LC-MS/MS run that could correspond to a compound present in the sample. For each 
compound, we calculated the theoretical mass M from its chemical composition and 
searched for the M+H, M+2H, M+K, and M+Na adducts. Putative identifications included 
all MS/MS spectra whose precursor m/z had a ppm error <50 compared to the theoretical 
mass of each possible precursor m/z; all tandem MS/MS spectra with an MS1 precursor 
intensity of <1E4 were ignored. All candidate identifications were manually inspected and 
the most abundant representative spectrum for each compound was added to the 
corresponding library at the gold or bronze level based upon an expert evaluation of the 
spectrum quality. The best MS/MS spectrum per compound as added to the GNPS-
Collections library without filtering or alteration from the mzXML files.
GNPS-Community Contributed Spectral Library Processing and Control
User contributed library spectra are not filtered or altered in any way from the user 
submission. MS/MS spectra are extracted from the submitted data and are made available in 
the GNPS libraries. The list and description of metadata fields can be found in GNPS online 
documentation. To preserve provenance information, the full input file is also retained and 
made available for download for each library spectrum (e.g. link). Different levels of 
reference spectra submissions are enforced with access restrictions on a per user basis. The 
description of each of the quality levels: Gold, Silver and Bronze and be found in 
Supplementary Table 3. While any MS/MS spectrum can be Bronze quality level in the 
GNPS libraries, Silver contributions require peer-reviewed publication of the MS/MS 
spectra, and Gold contributions require MS/MS spectra to be of synthetics or purified 
compounds with complete structural characterization.
Materials and Strains
Streptomyces sp. DSM5940, obtained from Eberhard-Karls-Universität Tübingen, Germany, 
was originally isolated from a soil sample collected from the Andaman Islands, India. 
Streptomyces roseosporus NRRL 15998 was acquired from the Broad Institute, MIT/
Harvard, MA, USA, whose parent strain S. roseosporus NRRL 11379 was isolated from soil 
from Mount Ararat in Turkey. All media components were purchased from Sigma-Aldrich. 
Organic solvents were purchased from JT Baker at the highest purity.
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Streptomyces sp. DSM5940 and S. roseosporus Metabolite Extraction
S. roseosporus and Streptomyces. sp. DSM5940 were inoculated by 4 parallel streaks onto 
individual ISP2 agar plates61. After incubating for 10 d at 28 °C, the agar was sliced into 
small pieces and put into a 50 mL centrifuge tube containing 1:1 water:n-butanol and shaken 
at 225 rpm for 12 h. The n-butanol layer was collected via transfer pipette, centrifuged, and 
dried with in vacuo.
Streptomyces sp. DSM5940 and S. roseosporus MS/MS Acquisition
MS/MS spectra for crude extracts of S. roseosporus and Streptomyces sp. DSM were 
collected as previously described37. Briefly, MS/MS spectra were collected using direct 
infusion using an Advion nanomate-electrospray robot and capillary liquid chromatography 
using a manually pulled 10 cm silica capillary packed with C18 reverse phase resin. Samples 
were introduced for capillary LC using a Surveyor system using a 10mL injection (10 ng/μL 
in 10% ACN). Metabolites were separated using a time variant gradient [(minutes, % of 
solvent B): (20, 5), (30, 60), (75, 95) where solvent A is water with 0.1% AcOH and B is 
ACN with 0.1% AcOH] using a 200mL flowrate (1% to instrument source with 1.8kV 
source voltage). Both methods utilized detection by a Thermo Finnigan LTQ/FT-ICR mass 
spectrometer. The mass spectrometer was operated in data dependent positive ion mode; 
automatically switching between full scan high resolution FT MS and low resolution LTQ 
MS/MS acquisitions. Full scan MS spectra were acquired in the FT and the top six most 
intense ions in a particular scan were fragmented using collision induced dissociation (CID) 
at a constant collision energy of 35eV, an activation Q of 0.25, and an activation time of 50 
to 80 ms. RAW files were converted to .mzXML using ReAdW.
Molecular Networking Parameters
A molecular network was created at GNPS data from the S. roseosporus and Streptomyces 
sp. DSM5940 MS/MS data. The specific job is browse-able online (link). Full parameters 
can be found in Supplementary Table 11.
Stenothricin-GNPS extraction and purification
400 ISP2 agar plates were inoculated with spore suspension of Streptomyces sp. DSM5940 
strain and incubated for 10 d at 30 °C. The agar was sliced into small pieces and extracted 
twice with 1:1 water:n-butanol for 12 h at 28 °C and 225 rpm in two 2.8 L Fernbach flasks. 
Agar pieces were removed by filtration. The resultant filtrate was centrifuged and the n-
butanol layer was collected, dried and resuspended in 1 mL methanol. The extract was 
fractionated using a Sephadex LH20 column utilizing a methanol mobile phase at a flow rate 
of 0.5 mL/min. Each fraction was analyzed by dried droplet MALDI-TOF MS for the m/z 
values corresponding to stenothricin-GNPS. For this analysis, 1 mL of each fraction was 
mixed 1:1 with a saturated solution of Universal MALDI matrix (Sigma-Aldrich) in 78 % 
acetonitrile containing 0.1 % TFA and spotted on a Bruker MSP 96 anchor plate. The 
sample was dried and analyzed by either a Microflex or Autoflex MALDI-TOF MS (Bruker 
Daltonics). Mass spectra were obtained using the FlexControl software and a single spot 
acquisition of 80 shots. MALDI-TOF MS data was analyzed by FlexAnalysis software. 
Fractions containing m/z values putatively assigned to stenothricin-GNPS were combined 
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and further purified by a two-step reversed-phase HPLC procedure (Solvent A: water with 
0.1% TFA; Solvent B: ACN with 0.1% TFA). Initial HPLC analysis (SUPELCO C18, 5 μm, 
100 Å, 250 × 10.0 mm) utilized a linear gradient from 50% to 75% solvent B in 35 min at 
flow rate 2 mL/min. Fractions containing target peptide m/z values as detected by MALDI-
TOF MS were collected, combined, and evaporated. Subsequent HPLC analysis (Thermo, 
Syncronis Phenyl HPLC, 5 μm, 150 × 4.6 mm) used an isocratic elution with 35% solvent B. 
Purified stenothricin-GNPS 2 (m/z 1091) and 3 (m/z 1105) were lyophilized and stored at 
−80 °C.
Stenothricin-GNPS NMR
50 μg stenothricin-GNPS 2 was dissolved in 30 μL of CD3OD for NMR acquisition. 1H-
NMR spectra were recorded on Bruker Avance III 600 MHz NMR with 1.7 mm Micro-
CryoProbe at 298 K, with standard pulse sequences provided by Bruker. The NMR spectrum 
was overlayed with the NMR spectrum from stenothricin D and analyzed using the 
MestReNova software37.
Genome sequencing and de novo assembly Streptomyces sp. DSM5940
Streptomyces sp. DSM5940 genome was subjected to partial genome sequencing by Ion 
Torrent and Illumina MiSeq with paired end sequencing. The resulting contigs were 
assembled by Geneious 5.1.1 using the S. roseosporus 15998 genome sequence as template. 
Sequences have been deposited in NCBI with accession number assignment pending.
Sequence definition of the gene cluster in Streptomyces sp. DSM5940
To identify the Strenothricin-GNPS gene cluster, the Streptomyces sp. DSM5940 genome 
was annotated using Artemis62,63. Non-ribosomal peptide synthesis (NRPS) biosynthetic 
gene clusters were manually assigned using the Artemis Comparison Tool (an “all-against-
all” BLAST (NCBI) comparison of proteins within the database)64. The adenylation 
domains of each NRPS gene cluster were further assessed using NRPSpredictor265,66. The 
predicted 10 amino acid codes for each A-domain within the NRPS gene clusters was 
manually compared to those predicted for the putative stenothricin gene cluster from S. 
roseosporus37. The gene cluster with highest A-domain similarity was putatively identified 
as the stenothricin-GNPS gene cluster. Full sequence alignment of both the stenothicin-
GNPS and stenothricin using ClustalW2 confirmed high sequence identity and similarity67.
Phylogenetic Analysis of C-domains
To determine whether the stenothricin and stenothricin-GNPS gene clusters code for similar 
amino acid stereochemistry, the condensation domain (C-domain) sequences in the putative 
stenothricin-GNPS and stenothricin gene clusters were aligned with a subset of C-domain 
sequences representing the six C-domain families (heterocyclization, epimerization, dual 
condensation/epimerization (dual), condensation of L amino acids to L amino acids (L to L), 
and condensation of D amino acids to L amino acids (D to L), and starter) using 
ClustalW267.
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Fluorescence Microscopy
A pre-culture of E. coli lptD cells (NR698) was grown to saturation, then diluted 1:100 into 
20 mL LB. Flasks were incubated at 30°C until an OD600 of 0.2 was reached. Cultures were 
then mixed with the appropriate amount of compound. Compounds were used at the 
following final concentrations: 1% MeOH, 0.5% DMSO, 20 μg/mL stenothricin D, 40 
μg/mL stenothricin-GNPS 2/3. 15 μL of treated cells were transferred into a 1.7 mL tube and 
incubated at 30°C in a roller. Samples were collected for imaging at 2 hours. 6 μL of cells 
were added to 1.5 μL of dye mix (30 μg/mL FM 4-64, 2.5 μM SYTOX green and 1.2 μg/mL 
DAPI) prepared in 1X T-base, and immobilized on an agarose pad (20% LB, 1.2% agarose) 
prior to microscopy. All microscopy was performed on an Applied Precision Spectris 
microscope as previous described68 Images were deconvolved using softWoRx V 5.5.1 and 
the medial focal plane shown. The SYTOX green images were normalized within Figure 5d 
based on intensity and exposure length relative to the treatment with the highest fluorescence 
intensity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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BOX 1
Views from GNPS end-users
Nature Biotechnology asked independent researchers to feedback on different aspects of 
GNPS. Their views are presented below.
Is this interface different to others available?
Respondent 1 (anonymous). The interface is different from others that are available. We 
laud the efforts of trying to combine as many mass spectra databases as possible and to 
provide analytical tools to help you hone in on significant aspects for your spectra. Our 
main concern about the User Interface is the complexity – it’s a bit difficult to 
navigate/use but it can likely be learned once you become familiar with the layout of the 
site and the intent of each page. Respondent 2 (Bo Li and Ashley Kretsch). This is the 
first interface of its kind that I have worked with, but I have limited experience in 
metabolomics and molecular networking prior to GNPS.
Comment by GNPS
There are many experiments possible with GNPS and therefore the complexity of the 
analysis depends on the complexity of each experiment. For example, while dereplication 
of a few LC-MS files can be done using an in-browser drag-and-drop interface, more 
complex network visualizations may require uploading metadata files, transferring of 
large mass spectrometry files using an FTP client, and exporting files from GNPS for 
offline visualization. To tackle this complexity, GNPS’s workflows have detailed step-by-
step written instructions and online instructional videos (linked to through 
“Documentation” on the banner at GNPS) In addition, the GNPS forum facilitates the 
answering of more detailed questions and assists with hands-on trouble shooting where 
both GNPS administrators as well as the community can provide feedback.
Does it offer unique and compelling features that mean you want to continue to use 
it?
Respondent 1. The major compelling feature of this tool is the network analysis of your 
spectra relative to all known spectra. This is an idea whose time has come that we hope 
will be useful. For our work, it is unlikely we will need/use this approach as our work is 
almost always driven by genetics. Where I imagine this will be useful is more classic 
"grind-n-find" or crude extract approaches where you could upload data without any idea 
of what’s in present, and if you're lucky, be given a clue about what is in your extract. 
The potential utility of this tool would be to guide an investigator to look at the extract 
that provided that anomalous peak. Respondent 2. Having the networking available on 
the website platform allows for fast and efficient evaluation of compound clusters without 
having to upload and annotate in cytoscape. In addition, this is a great tool to be able to 
compare MSMS spectra directly between two linked compounds. This has been 
especially useful when working with novel compounds, where the structure for one might 
be unknown.
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Comment by GNPS
The analysis capabilities provided by GNPS enable a shift in thinking about one 
molecule in isolation to thinking about relationships between all molecules included in a 
sample, collection of samples or even worldwide shared data from a wide variety of 
samples. GNPS can be used to organize entire culture collections based on the detected 
molecules and allows one to make this data privately shareable within a lab or publically 
accessible to the community at large. For example, one possible way to use public data is 
to search it for molecules or analogs to find the highest titer producer. There are also 
several examples in the literature that already used GNPS molecular networking to link 
mass spectrometry data to the underlying genetics. Molecular networking has been used 
to study biosynthesis (to observe the impact of gene knock-outs or heterologous 
expression of natural product pathways on metabolite production) and has facilitated 
mass spectrometry based genome mining (references provided in the main text). One can 
begin linking metadata (e.g. bioactivity) to understand what parts of an extract are 
responsible for activity or even perform structure activity relationship or metabolism 
studies without the need for label. We can now imagine developing automated tools for 
genetic manipulation and performing mass spectrometry screens on 100,000s of samples 
that can then be analyzed in GNPS. Currently there is no other computational 
infrastructure capable of molecular analysis at such scales.
How straightforward is it to upload spectra and run tests on your data?
Respondent 1. We didn't try this. Respondent 2. The tutorials are easy to follow, once you 
have uploaded and analyzed data once it is easy to repeat the process. Any questions I 
have had are also answered in a very timely manner via email.
Comment by GNPS
We recognize that learning a new platform for the first time, even with written 
documentation, video tutorials, community forum, and prepopulated demonstration 
analyses, is a very daunting task. To make the process easier, we have included links to 
the appropriate documentation/videos for uploading/running a user’s first analysis 
directly on the data analysis page.
Would you consider using this interface to deposit all spectra/experiments straight 
into the database as you work?
Respondent 1. Probably not. The main issue we would be concerns about the privacy of 
the data. If this was a community-agreed upon repository for post-publication deposition, 
we would consider it. (editors note: data can be made private if wished). Respondent 2. 
My work deals mostly with comparative metabolomics and structure identification, so my 
data might not be useful for the metabolite community as a whole compared to some of 
these broader databases. I like the feature where you can pick what data is accessible to 
the whole group and what is private to the user.
Comment by GNPS
All GNPS user data is considered private until users explicitly decide to make it public 
through GNPS workflows designed solely for data sharing. But while private data can 
always be manually re-searched using frequently updated GNPS libraries, we do 
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emphasize that making data public has the advantage that it becomes part of the living 
data space where new knowledge from continuous identification is seamlessly shared and 
automatically disseminated to all subscribers.
Do you think there are problems with existing databases for MS?
Respondent 1. For our case they work fine, but as I mentioned we usually have 1) genetic 
information and 2) purified compounds. For this case the existing databases are fine. 
Respondent 2. We find that with our smaller molecules, our library hits can be unrelated 
to our compounds despite a high cosine score. This might be due to the low number of 
fragments (ie for compounds less that 200)
Comment by GNPS
Having MS/MS of pure compounds in GNPS is incredibly valuable for the community. 
They provide the ability of non-natural product scientists to search their data. For 
example, a microbiome person may be aiming to understand the biology of a soil 
community or a gut community and find matches to purified standards. This is akin to 
someone who studied an enzymatic reaction in detail and deposited this information in 
GenBank as this information has much wider utility. Regarding matches to small 
molecules, this is unfortunately a known inherent limitation of the chemical properties of 
small molecules in the gas phase –there will indeed be fewer fragment ions with small 
molecules and these are indeed more challenging to match than larger molecules that 
generate more fragment ions. We recommend a minimum of 6 MS/MS fragment ions to 
match in addition to the parent mass and we show in supplementary materials how these 
settings result in very low estimated false discovery rates. However, if one relaxes these 
constraints for dereplication or molecular networking (as is possible in GNPS) then the 
number of incorrect matches can indeed increase. While GNPS-based analysis is 
powerful, we always advise validation of results with additional methods as one does 
with any other large scale omics analysis pipeline, as these approaches typically enable 
the formulation of many hypotheses. For example, one could use additional information 
or metadata (such as species or origin) to corroborate identification results. Further, one 
could perform careful retention time analysis, co-migration with standards, or subsequent 
isolation and NMR analysis to validate key results.
Are the social features appealing (live data?)
Respondent 1. The main issue for us with the live data idea is that the social aspects are 
only useful if there is some agreement about data use. The hope for the GPNS platform is 
a Google-like scaling effect where as you get more data, you get better at making 
predictions. This virtuous cycle is virtuous only if you can benefit from it - so the social 
problem is that whoever controls this data set has an advantage, potentially at the expense 
of the depositor. Respondent 2. I think it is very helpful for ongoing experiments. As 
more knowledge is generated, this is carried over to your data, much like a system 
update. As the field continues to expand and GNPS is more widely used, this will 
enhance the overall experience of the platform.
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Comment by GNPS
We emphasize that in the GNPS vision of “by the community for the community”, all 
GNPS public data, spectral libraries, data analysis workflows and continuous 
identification results are publically, immediately and freely available to all users, not just 
GNPS administrators. In difference from Google searches, a more related analogy could 
be to compare GNPS to the community process of determining gene annotations and 
making genomic information accesible –if no one had shared gene annotations that were 
carefully curated in a community-wide platform, BLAST would not be very informative. 
We further note that in the same way that the openness of NCBI repositories (e.g., 
GenBank) and algorithms (e.g., BLAST) have not resulted in ‘unfair advantages’ for NIH 
intra-mural researchers, we also expect that the openness of GNPS data and algorithms 
will enable researchers equally across the community, regardless of their affiliation or 
geographical location (a trend that is already supported by the GNPS community 
including users from 100+ countries, several of which have already published 
independently of GNPS administrators). The use of mass spectrometry data in this 
fashion is probably where gene sequencing and genome sharing were over a decade ago. 
Utilizing the same data and mechanisms available to the community, we have developed 
several tools that are now widely used by the community. Further, members of the 
community have also leveraged this openness of data to develop new computational 
methods. It should also be noted that community members have benefited substantially 
from the openness of data at GNPS, with 83.6% of identifications made in public data by 
matching to reference spectra uploaded to GNPS by another member of the community. 
Moreover, users have aided their own analyses by utilizing other’s public data in 3,145 
instances. Finally, users can post feature requests in the GNPS forums and we will 
consider coordination, integration, or implementation of efforts to enhance the utility of 
the public data.
Is the openness an enabling and attractive feature?
Respondent 1. Not really. While openness is a good trend we believe the primary 
beneficiaries of the openness is almost always those who are running the platform. 
Respondent 2. Yes, it influences a sense of collaboration in the metabolomics field. For 
instance, we have been investigating secondary metabolites in Bukrholderia cenocepacia. 
By looking at our data in comparison to samples taken from the CF lung, we can explore 
how B. cenocepacia is involved in infection at a chemical level
Comment by GNPS
Sharing data is becoming a requirement by funding agencies because it extensively 
benefits the whole research community. For example, Genbank is an open repository that 
has become all but indispensable in genomics research. GNPS aims to meet this pressing 
need in the natural product field with respect to mass spectrometry. Further supporting 
the substantial community-wide benefits of data sharing, we are already observing that 
83.6% of identifications made in public data were derived by matching to reference 
spectra uploaded to GNPS by another member of the community. In addition to these 
benefits, the open availability of GNPS reference spectra and public data have also 
already driven the development of new bioinformatics tools. Last but not least, we 
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emphasize the example provided by Respondent 2 of one way in which the availability of 
open data combined with open algorithms can be used to support new discoveries – a 
usage pattern that we have found to be popular at GNPS as many users now import data 
from other datasets to aid or extend the scope of their own research.
Are there creative aspects of GNPS that you feel deserve highlighting?
Respondent 1. The clustering idea is a great idea. Or rather, the idea of applying 
computational techniques to large scale datasets to direct experimental research is a first-
rate idea. As the data accrues, it may be true that the predictive power of these spectra get 
better and better. So we would say that the creativity is actually in keeping the idea 
simple (clustering spectra with similarly occurring peaks). This will hopefully allow the 
scaling of data to the point that old data begins to provide useful clues that would have 
been difficult to achieve at smaller scales. Respondent 2. The web interface, especially 
the networks, where clicking between two compounds shows a side by side comparison, 
points can be labeled by library hits or m/z values, size can be proportional to intensity, 
and color coded by what groups this compound is included in. It allows easy transition to 
view all of the available features of each compound.
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Figure 1. Overview of GNPS
(a) Representation of interactions between the natural product community, GNPS spectral 
libraries, and GNPS datasets. At present 221,083 MS/MS spectra from 18,163 unique 
compounds are used for the search in the GNPS. These include both 3rd party libraries such 
as MassBank, ReSpect, and NIST, as well as spectral libraries created for GNPS (GNPS-
Collections) and spectra from the natural product community (GNPS-Community). GNPS 
spectral libraries grow through user contributions of new identifications of MS/MS spectra. 
To date, 55 community members have contributed 8,853 MS/MS spectra from 5,568 unique 
compounds (30.5% of the unique compounds available). In addition, on-going curation 
efforts have already yielded 563 annotation updates for library spectra. The utility of these 
libraries is to dereplicate compounds (recognition previously characterized and studied 
known compounds), in both public and private data. This dereplication process is performed 
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on all public datasets and results are automatically reported, thus enabling users to query all 
datasets/organisms/conditions. Automatic reanalysis of all public data creates a virtuous 
cycle in which contributions to libraries can be matched to all public data. Combined with 
molecular networking (Fig. 3), this automatic reanalysis empowers community members to 
identify analogs that can then be added to GNPS spectral libraries. (b) The GNPS platform 
has grown to serve a global user base of 9,200+ users from 100 countries.
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Figure 2. GNPS spectral libraries
(a) The computational resources of the metabolomics and natural products community fall 
into two main categories: i) Reference collections (red dots) of MS/MS spectral libraries and 
ii) Data Repositories (blue dots)designed to publicly share raw mass spectrometry data 
associated with research projects. Reference collection resources are contributors and 
aggregators of reference MS/MS spectra, some of which also include data analysis tools, e.g. 
online multi-spectrum MS/MS search (magnifying glass icon). Several resources have 
aggregated MS/MS spectra from various reference collections so that the analysis tools at a 
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respective resource can leverage more of the community efforts to annotate data (red and 
blue arrows). GNPS has imported all freely available reference collections (>221,000 
MS/MS spectra) and makes them available for online analyses. GNPS and several other 
resources provide both reference MS/MS spectra and data in an open and free manner to the 
public (pink caps). (b) Comparison of spectral library sizes of available libraries (MassBank, 
ReSpect, and NIST) and GNPS libraries; GNPS-Collections includes newly acquired spectra 
from synthetic or purified compounds and GNPS-Community includes all community-
contributed spectra. (c) Searching all public GNPS datasets revealed that Massbank/
ReSpect/NIST libraries matched to 1,217 unique compounds, with GNPS libraries 
increasing unique compound matches by 41% (corresponding to 29% of total unique 
matches) with an accompanying 4% increase in spectral library size. Overall, GNPS libraries 
increase the total number of spectra matched in public datasets by 144% (59% of total public 
MS/MS matches) and spectra matches across all GNPS public and private data by 767% 
(88% of all MS/MS matches). (d) The distribution of precursor masses in all GNPS public 
datasets is shown in gray and compared to the precursor mass distributions of Massbank, 
ReSpect, NIST, and GNPS libraries. Though GNPS libraries have a combined size that is 
smaller than MassBank/ReSpect/NIST, GNPS libraries have a higher proportion of 
molecules in the higher m/z range and therefore complement the proportionately lower 
precursor mass molecules in other libraries. (e) The quality of spectrum matches obtained by 
searching against the available spectral libraries is assessed by user ratings (1 to 4 stars see 
Supplementary Table 6) of continuous identification results. User ratings of 2.5+ stars for 
98%+ of GNPS library matches compares favorably with the 90% mark for NIST matches, 
whose high marks demonstrate how important these 3rd party libraries still are to the GNPS 
platform. We note that the lower mark for NIST matches does not suggest lower quality 
spectra. It is more likely explained by its higher emphasis on lower precursor mass 
molecules with spectra that have fewer peaks and are generally harder to match.
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Figure 3. Molecular Network Creation and Visualization
(a) Molecular networks are constructed from the alignment of MS/MS spectra to one 
another. Edges connecting nodes (MS/MS spectra) are defined by a modified cosine scoring 
scheme determines the similarity of two MS/MS spectra with scores ranging from 0 (totally 
dissimilar) to 1 (completely identical). MS/MS spectra are also searched against GNPS 
Spectral Libraries, seeding putative nodes matches in the molecular networks. Networks are 
visualized online in-browser or exported for third party visualization software such as 
Cytoscape31. (b) An example alignment between three MS/MS spectra of compounds with 
structural modifications that are captured by modification tolerant spectral matching utilized 
in variable dereplication and molecular networking. (c) In-browser molecular network 
visualization enables users to interactively explore molecular networks without requiring any 
external software. To date, more than 11,000 molecular networks have been analyzed using 
this feature. Within this interface, (i) users are able to define cohorts of input data and 
correspondingly, nodes within the network are represented as pie charts to visualize spectral 
count differences for each molecule across cohorts. (ii) Node labels indicate matches made 
to GNPS spectral libraries, with additional information displayed with mouseovers. These 
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matches provide users a starting point to annotate unidentified MS/MS spectra within the 
network. (iii) To facilitate identification of unknowns, users can display MS/MS spectra in 
the right panels by clicking on the nodes in the network, giving direct interactive access to 
the underlying MS/MS peak data. Furthermore, alignments between spectra are visualized 
between spectra in the top right and bottom right panels in order to gain insight as to what 
underlying characteristics of the molecule could elicit fragmentation perturbations.
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Figure 4. “Living data” in GNPS by crowdsourcing molecular annotations
(a) A global snapshot of the state of MS/MS matching of public natural product datasets 
available in GNPS using molecular networking and library search tools. Identified molecules 
(1.9% of the data) are MS/MS spectrum matches to library spectra with a cosine greater than 
0.7. Putative Analog Molecules (another 1.9% of the data) are MS/MS spectra that are not 
identified by library search but rather are immediate neighbors of identified MS/MS spectra 
in molecular networks. Identified Networks (9.9% of the data) are connected components 
within a molecular network that have at least one spectrum match to library spectra. 
Unidentified Networks (25.2% of the data) are molecular networks where none of the 
spectra match to library spectra; these networks potentially represent compound classes that 
have not yet been characterized. Exploratory Networks (an additional 20.1% of the data) are 
unidentified connected components in molecular networks with more relaxed parameters 
(Supplementary Table 8). Thus, 55.3% of the MS/MS spectra at least have one related 
MS/MS spectrum in spectral networks, with 44.7% having none. In this 44.7% of the data, 
each MS/MS spectrum has been observed in two separate instances and should not 
constitute noise. Altogether, this analysis indicates that most of the chemical space captured 
by mass spectrometry remains unexplored. (b) In the past year, there has been significant 
growth in the GNPS spectral libraries, driving growth in the match rates of all public data. 
The number of unique compounds matched in the public data has increased 10x; the number 
of total spectra matched has increased 22x; and the average match rate has increased 3x. It is 
expected that identification rates will continue to grow with further contributions from the 
community to the GNPS-Community spectral library.
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Figure 5. GNPS enabled discovery of stenothricin
a) The stenothricin molecular family was identified during analysis of a molecular network 
between chemical extracts of S. roseosporus NRRL 15998 (Green) and Streptomyces sp. 
DSM5940 (Blue). This analysis indicates that Streptomyces sp. DSM5940 produces a 
structurally similar compound to stenothricin with a −41 Da m/z difference. An enlarged 
version of the network can be found in Supplementary. b) Based on preliminary structural 
analysis, stenothricin-GNPS (41 Da) may contain a Lys to Ser substitution. c) Comparison 
of the MS/MS of stenothricin D with stenothricin-GNPS 2. d) Although structurally related, 
stenothricin and stenothricin-GNPS have different effects on E. coli as visualized using 
fluorescence microscopy. Red is the membrane stain FM4-64, blue is the membrane 
permeable DNA stain DAPI, green is the membrane impermeable DNA stain SYTOX green. 
SYTOX green only stains DNA when the cell membrane is damaged. The scale bar 
represents 2 μm.
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Table 1
Metabolomics and Natural Products MS/MS Computational Resources Overview
Summary Data repository*
Reference
collections^
Open online data
analysis& Reference
GNPS
Natural products and
metabolomics 
crowdsourced
analysis platform with 
public
reference libraries, public 
data
repository and living data
Yes, with automated
reanalysis, minimal
required metadata 
(220
w/MS2, 274 total)
Yes, open
access,
crowdsourced
curation
Can search any number
of files, analog searches
and molecular
networking
(G,J,E,NA,R,H,N)
Reference Collections
MassBank Japan
The first public large 
scale
database for 
metabolomics
reference spectra.
Yes, open
access
Can search up to one 
file
at a time
(J)
5
MassBank Europe
European counterpart of
massbank japan. This 
public
reference spectral library 
is
under construction to 
include
draft structures.
Yes, open
access
Can search up to one 
file
at a time
(J,E)
MassBank North America
North American public
spectral library warehouse
and distribution database.
Yes, open
access
Can search up to one 
file
at a time (G,J,NA,R,H)
ReSpect
Public reference library 
for
plant metabolites.
Yes, open
access
Can search single
spectrum
(R)
8
HMDB
Public reference library 
for
human metabolites.
Yes, open
access
Can search single
spectrum
(H)
55
XCMS-online/Metlin
Reference library for
metabolomics. Can be
searched but the library is
commercial and not 
available
for public redistribution.
Yes, no reanalysis (10
w/MS2, 23 total)
Yes, not freely
available
Can search any number
of files up to 25Gb
(Mt)
6
NIST/EPA/NIH
Reference libraries for
metabolomics. Accessible
through purchase but not
available for 
redistribution.
Yes, not freely
available
mzCloud
A metabolomics search 
engine
and reference library. The
library is not available to 
the
scientific community.
Yes, not freely
available
Data Repositories
Metabolights
Public data repository for
metabolomics data, 
library
capabilities under
construction.
Yes, no reanalysis,
experimental 
metadata
(13 w/MS2, 131 
total)
Aggregator
only
34
Metabolomics workbench Public data repository for
metabolomics data.
Yes, no reanalysis,
extensive metadata
required (9 w/open
Aggregator
only
56
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Summary Data repository*
Reference
collections^
Open online data
analysis& Reference
format MS2, 196 
total)
*
Data repository – denotes whether a resource is designed to publicly share projects data with the community or between different research groups. 
Total number of MS/MS datasets and total datasets are shown in parenthesis.
^
Reference collection of MS/MS spectra – indicates whether resources contribute new MS/MS reference spectra to spectral libraries (rather than 
redistributing them); mode of access to download the MS/MS reference spectra is clarified.
&Online analysis utilizing MS/MS reference spectra available at each resource, with emphasis on batch capabilities; the MS/MS spectral libraries 
available for searches at each resource are highlighted with the following notation: GNPS libraries (G), MassBank JP libraries (J), MassBank EU 
libraries (E), MassBank of North America libraries (NA), HMDB libraries (H), ReSpect libraries (R), NIST libraries (N), Metlin libraries (Mt), 
mzCloud libraries (Mz).
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